Description
FORMA FARMACÉUTICA: 15 COMPRIMIDOS
indicado para el tratamiento de infecciones fúngicas invasivas graves
Forma farmacéutica: Polvo para concentrado para solución para infusión
XYNTHASOL INY 250 UI | Frasco Ámpula | Factor de Actividad | 1 UN | CSL Behring
Cáncer diferenciado de tiroides refractario al yodo radiactivo
SELEDUM 120 MG 7 TAB OLANZAPINA FORMA FARMACÉUTICA: 15 COMPRIMIDOSPRINCIPIO ACTIVO: ETORICOXIB
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
